Navigation Links
Anti-obesity drugs for FDA approval

Two obesity reducing drugs are awaiting FDA approval and if approved could provide the pharmaceutical manufactures with high profits due to sales of these drugs. These new drugs are to be reviewed by the federal regulators before it could be available as a counter sales drug.// Acomplia and Alli are the two new anti-obesity drugs and could help in weight loss management.

Acomplia is manufactured by Sanofi-Aventis and the drug acts by controlling the brain signals which triggers signals for controlling appetite and stimulation to eat more. Alli is produced by GlaxoSmithKline which acts by controlling the body’s fat absorption leading to weight loss, Alli is available in drug market under the trade name of xenical, which on clinical trials was found not to cause any adverse effects and was found to reduce 12.4 pounds of weight on an average six months of taking the drug.


'"/>




Page: 1

Related medicine news :

1. Canada Confronts Obesity Head-on, Anti-obesity Campaign on Fast Track
2. Cancer drugs in development nearly doubled since 1995
3. Cipla holds talks with mining giant to supply AIDS drugs for South African workers
4. African HIV strains more resistant to anti HIV drugs
5. Right drugs drastically cut stroke risk
6. Relating heart protection and antihypertensive drugs
7. Enzyme may be target for obesity drugs
8. New HIV cases resist drugs
9. Relief to pregnant women using fertility drugs
10. AIDS drugs linked to heart attack risk
11. FDA debates status of decongestant drugs
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Anti obesity drugs for FDA approval

(Date:11/28/2014)... 2014 (HealthDay News) -- People with diabetes face a number ... keep you healthy, an expert says. "With the holidays ... with the events, the family you,ll be visiting and all ... of Diabetes Educators, said in an association news release. "By ... healthy." One idea is to make a healthy eating ...
(Date:11/28/2014)... 2014 BambooFlooringChina.com has been recognized as ... Recently, the business has announced its new strand ... big discount on these new models. , Based on ... hands, without carpenter machines involved. It is crafted on ... great for do-it-yourselfers without hard work on installation, also ...
(Date:11/28/2014)... Dr. Diane Walder, one of the South ... Dr. Bridgit Nolan to her practice as a cosmetic ... her dermatology residency at the University of Miami Miller ... Nolan to join her practice because of her ... only does Dr. Nolan strive to provide the utmost ...
(Date:11/28/2014)... (PRWEB) November 28, 2014 Dr. Andrew ... surgeons , announced the expansion of Quintessa Aesthetic Center ... will be located at W307 N1497 Golf Road in ... According to Dr. Campbell, the new Delafield location will ... for patients, including: Botox, filler injectables , ...
(Date:11/28/2014)... Melbourne, Australia (PRWEB) November 28, 2014 ... has undergone healthy growth over the past five ... population's increasing acceptance of therapies that are either ... conventional treatments. According to IBISWorld industry analyst David ... the ageing population and growing private health insurance ...
Breaking Medicine News(10 mins):Health News:Holiday Eating Tips for People With Diabetes 2Health News:BambooFlooringChina.com Introduces Its New Strand Woven Bamboo Flooring Collection 2Health News:Dr. Diane Walder Welcomes New Cosmetic Dermatologist to Practice 2Health News:Dr. Andrew Campbell to Expand Quintessa Aesthetic Center into Delafield 2Health News:Alternative Health Therapies in Australia Industry Market Research Report Now Updated by IBISWorld 2Health News:Alternative Health Therapies in Australia Industry Market Research Report Now Updated by IBISWorld 3Health News:Alternative Health Therapies in Australia Industry Market Research Report Now Updated by IBISWorld 4
... For the second consecutive year, the United States ... Birth Report Card, demonstrating that more than half a million ... deserved. In the 2009 Premature Birth Report card, seven ... fared worse. Criteria that affect preterm birth improved in many ...
... , SPRINGFIELD, Ohio, Nov. 16 AdCare Health Systems, ... term care, home care and management company, today reported financial ... the quarter ended September 30, 2009 were $6,909,499 as compared ... of $723,739. The increase was mostly due to better occupancy ...
... federal recommendations, , MONDAY, Nov. 16 (HealthDay News) -- ... for breast cancer until they,re 50, and they only ... government guidelines suggest. , Also, breast self-exams, which women ... lower the death rate from breast cancer, the guidelines ...
... A new poll of AARP members released today finds strong ... care reform included in the Affordable Health Care for America ... AARP-backed bill limits how much more insurance companies can charge ... doughnut hole. , Among AARP members, strong majorities reported ...
... , WEIFANG, ... SGTI) ("Shengtai" or "the Company"),a leading manufacturer and distributor of ... for the first,quarter of fiscal 2010 ended September 30, 2009. ... -- First quarter 2010 revenues totaled $23.13 ...
... cells that surround cancer cells within and around a ... effectiveness of traditional anti-cancer treatments, say researchers at The ... Investigation published online November 16, they demonstrate the ... one type of these so-called "stromal" cells, in promoting ...
Cached Medicine News:Health News:US gets a 'D' for preterm birth rate 2Health News:AdCare Health Systems, Inc. Reports 2009 Third Quarter Earnings Results; Third Consecutive Profitable Quarter 2Health News:AdCare Health Systems, Inc. Reports 2009 Third Quarter Earnings Results; Third Consecutive Profitable Quarter 3Health News:AdCare Health Systems, Inc. Reports 2009 Third Quarter Earnings Results; Third Consecutive Profitable Quarter 4Health News:AdCare Health Systems, Inc. Reports 2009 Third Quarter Earnings Results; Third Consecutive Profitable Quarter 5Health News:AdCare Health Systems, Inc. Reports 2009 Third Quarter Earnings Results; Third Consecutive Profitable Quarter 6Health News:AdCare Health Systems, Inc. Reports 2009 Third Quarter Earnings Results; Third Consecutive Profitable Quarter 7Health News:AdCare Health Systems, Inc. Reports 2009 Third Quarter Earnings Results; Third Consecutive Profitable Quarter 8Health News:AdCare Health Systems, Inc. Reports 2009 Third Quarter Earnings Results; Third Consecutive Profitable Quarter 9Health News:AdCare Health Systems, Inc. Reports 2009 Third Quarter Earnings Results; Third Consecutive Profitable Quarter 10Health News:Guidelines Delay Start of Mammograms to Age 50, Then Every Other Year 2Health News:Guidelines Delay Start of Mammograms to Age 50, Then Every Other Year 3Health News:Guidelines Delay Start of Mammograms to Age 50, Then Every Other Year 4Health News:Survey Finds AARP Members Back Health Care Reform Legislation 2Health News:Shengtai Pharmaceutical, Inc. Reports First Quarter Fiscal Year 2010 Financial Results 2Health News:Shengtai Pharmaceutical, Inc. Reports First Quarter Fiscal Year 2010 Financial Results 3Health News:Shengtai Pharmaceutical, Inc. Reports First Quarter Fiscal Year 2010 Financial Results 4Health News:Shengtai Pharmaceutical, Inc. Reports First Quarter Fiscal Year 2010 Financial Results 5Health News:Wistar researchers show targeting 'normal' cells in tumors slows growth 2Health News:Wistar researchers show targeting 'normal' cells in tumors slows growth 3
(Date:11/27/2014)... 2014 - New Solution That ... JIN Co., Ltd. will launch JINS MEME "ACADEMIC ... 500,000 yen or $5,000 (without tax /including two pairs of ... is a dedicated solution of "JINS MEME" to academic researchers, ... data* generated by electrooculography and six-axis sensors without API. (*Physiological ...
(Date:11/26/2014)... 2014  Aethlon Medical, Inc. (OTCQB:AEMD), announced today that ... approximately $3.3 million at a price of $0.30 per ... focused investor. Each unit consists of one common share ... warrant. Each whole warrant entitles the holder to acquire ... a period of five years from closing.  ...
(Date:11/26/2014)... 2014  Genomic Health, Inc. (Nasdaq: GHDX ) ... Executive Officer and President, will participate in the 26 ... New York Palace Hotel in New York ... Eastern Time (ET). To access the live ... to the  Investor Relations  section of the company,s web ...
Breaking Medicine Technology:JIN to Launch JINS MEME ACADEMIC PACK in Late April 2015 2JIN to Launch JINS MEME ACADEMIC PACK in Late April 2015 3Aethlon Medical Announces $3.3 Million Equity Investment 2Aethlon Medical Announces $3.3 Million Equity Investment 3Genomic Health to Present at the 26th Annual Piper Jaffray Healthcare Conference 2Genomic Health to Present at the 26th Annual Piper Jaffray Healthcare Conference 3
... 8 Alpharma Inc. (NYSE: ALO ... results from,clinical trials that showed ALO-01 (EMBEDA(TM)) ... clinically relevant features addressing abuse liability,alongside a ... I and II,studies, presented at the 27th ...
... Annual Meeting of the American Pain Society ... ... with lacosamide,demonstrated sustained pain relief from diabetic neuropathic pain (DNP),compared to placebo-treated ... Pain Society (APS) in Tampa, Fla., "This is the first placebo-controlled ...
Cached Medicine Technology:Alpharma Presents Data Addressing Abuse Liability Features, Safety and Efficacy on ALO-01 (EMBEDA(TM)) (morphine sulfate extended-release with sequestered naltrexone hydrochloride) at the American Pain Society Annual Scientific Session 2Alpharma Presents Data Addressing Abuse Liability Features, Safety and Efficacy on ALO-01 (EMBEDA(TM)) (morphine sulfate extended-release with sequestered naltrexone hydrochloride) at the American Pain Society Annual Scientific Session 3Alpharma Presents Data Addressing Abuse Liability Features, Safety and Efficacy on ALO-01 (EMBEDA(TM)) (morphine sulfate extended-release with sequestered naltrexone hydrochloride) at the American Pain Society Annual Scientific Session 4Alpharma Presents Data Addressing Abuse Liability Features, Safety and Efficacy on ALO-01 (EMBEDA(TM)) (morphine sulfate extended-release with sequestered naltrexone hydrochloride) at the American Pain Society Annual Scientific Session 5Alpharma Presents Data Addressing Abuse Liability Features, Safety and Efficacy on ALO-01 (EMBEDA(TM)) (morphine sulfate extended-release with sequestered naltrexone hydrochloride) at the American Pain Society Annual Scientific Session 6Alpharma Presents Data Addressing Abuse Liability Features, Safety and Efficacy on ALO-01 (EMBEDA(TM)) (morphine sulfate extended-release with sequestered naltrexone hydrochloride) at the American Pain Society Annual Scientific Session 7New Lacosamide Data Provides Evidence for Long-Term Efficacy in Diabetic Neuropathic Pain 2New Lacosamide Data Provides Evidence for Long-Term Efficacy in Diabetic Neuropathic Pain 3New Lacosamide Data Provides Evidence for Long-Term Efficacy in Diabetic Neuropathic Pain 4
... has the right product for any patient ... intubated patients to patients with tracheotomies. These ... and critical care applications., ,The Unti-Mist ... patients and staff members. This entire product ...
Passive heat and moisture exchangers for respiratory applications....
Passive heat and moisture exchangers for respiratory applications....
Ballard trach care HMES and filters, tv 1500, HME...
Medicine Products: